子痫前期与子痫:综合征概念演变
本文回顾子痫前期从以惊厥(即子痫)识别的中枢神经系统疾病,演变为主要以血管性疾病认识的概念变迁。文章综述支持以舒张期高血压和蛋白尿作为诊断标准的流行病学数据,并讨论胎盘抗血管生成因子释放、早发型与晚发型子痫前期的不同特征,以及子痫前期患者后续高血压、缺血性心脏病等风险。
要点
- 子痫前期曾被认作中枢神经系统疾病,现主要概念化为血管性疾病。
- 舒张期高血压与蛋白尿联合存在与胎儿死亡及小于胎龄儿风险增加相关。
- 子痫前期为多系统疾病,表现多变,即使无高血压和蛋白尿也可存在。
核心结论
- 子痫前期是胎盘引起的妊娠特异性疾病,仅分娩可治愈,今天理解为妊娠暴露或引起的血管功能障碍。
- 早发型子痫前期与动脉粥样硬化有许多共同特征,晚发型子痫前期似乎源于胎儿需求与母体供应的不匹配,即代谢危机。
- 部分诊断为子痫前期的患者后续发生高血压、缺血性心脏病、心力衰竭、血管性痴呆和终末期肾病的风险更高,但这些不良事件可能源于既存的血管病理过程,子痫前期是否增加基线风险尚不清楚。
研究设计与样本
- 原文未报告研究设计。
- 原文未报告样本量。
主要发现
- 舒张期高血压与蛋白尿联合存在与胎儿死亡风险增加及小于胎龄儿出生相关,此流行病学数据支持将其作为诊断标准。
- 子痫前期为多系统疾病,表现多变,即使无高血压和蛋白尿也可存在。
- 一个多世纪以来寻找 putative 毒素的工作充满挑战,越来越多证据提示缺血或应激胎盘产物参与该综合征的血管改变。
- 胎盘可产生抗血管生成因子,调节内皮细胞功能并诱导血管内炎症,是理解子痫前期的重要进展。
- 胎盘释放抗血管生成因子被视为通过调节内皮功能和母体心血管表现改善子宫灌注的适应性反应,但该稳态反应可失适应并在妊娠期或产后导致靶器官损伤。
关键数值与推荐
- 原文未报告具体诊断阈值或推荐等级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia, one of the most enigmatic complications of pregnancy, is considered a pregnancy-specific disorder caused by the placenta and cured only by delivery. This article traces the condition from its origins-once thought to be a disease of the central nervous system, recognized by the occurrence of seizures (ie, eclampsia)-to the present time when preeclampsia is conceptualized primarily as a vascular disorder. We review the epidemiologic data that led to the recommendation to use diastolic hypertension and proteinuria as diagnostic criteria, as their combined presence was associated with an increased risk of fetal death and the birth of small-for-gestational-age neonates. However, preeclampsia is a multisystemic disorder with protean manifestations, and the condition can be present even in the absence of hypertension and proteinuria. Toxins gaining access to the maternal circulation have been proposed to mediate the clinical manifestations-hence, the term "toxemia of pregnancy," which was used for several decades. The search for putative toxins has challenged investigators for more than a century, and a growing body of evidence suggests that products of an ischemic or a stressed placenta are responsible for the vascular changes that characterize this syndrome. The discovery that the placenta can produce antiangiogenic factors, which regulate endothelial cell function and induce intravascular inflammation, has been a major step forward in the understanding of preeclampsia. We view the release of antiangiogenic factors by the placenta as an adaptive response to improve uterine perfusion by modulating endothelial function and maternal cardiovascular performance. However, this homeostatic response can become maladaptive and lead to damage of target organs during pregnancy or the postpartum period. Early-onset preeclampsia has many features in common with atherosclerosis, whereas late-onset preeclampsia seems to result from a mismatch of fetal demands and maternal supply, that is, a metabolic crisis. Preeclampsia, as it is understood today, is essentially vascular dysfunction unmasked or caused by pregnancy. A subset of patients diagnosed with preeclampsia are at greater risk of the subsequent development of hypertension, ischemic heart disease, heart failure, vascular dementia, and end-stage renal disease. However, these adverse events may be the result of a preexisting vascular pathologic process; it is not known if the occurrence of preeclampsia increases the baseline risk. Therefore, the understanding, prediction, prevention, and treatment of preeclampsia are healthcare priorities.
引用
- Erez O, Romero R, Jung E, et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol. 2022. PMID: 35177220. doi:10.1016/j.ajog.2021.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。